Europe Chafes at Slow Pace of Covid-19 Vaccine Approval
Updated Dec. 15, 2020 10:20 am ET The European Unionâs chief drug regulator will accelerate its review of a Covid-19 vaccine after coming under pressure from some governments to authorize the shot, as the continent struggles to contain a wave of cases ahead of the Christmas period. The European Medicines Agency said on Tuesday it would meet on Dec. 21, eight days earlier than previously scheduled, to consider authorizing the shot developed by Germanyâs BioNTech SE and Pfizer Inc. So far, the U.S., U.K. and Canada have begun vaccinating their citizens with the shot. Once ...